No Jitter is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Research Library

The top resource for free research, white papers, reports, case studies, magazines, and eBooks.

Life Sciences > Drug Discovery
Share Your Content with Us
on TradePub.com for readers like you. LEARN MORE
Use of Metabolomics to Phenotype and Categorize Risk in Human Health Studies Accelerates Clinical Care and Drug Development

Request Your Free Research Report Now:

"Use of Metabolomics to Phenotype and Categorize Risk in Human Health Studies Accelerates Clinical Care and Drug Development"

VIEW NOW

Presented at: Gordon Research Conference -- Metabolomics and Human Health March 12-15, 2023

Nontargeted metabolomics and both genome-wide association study (GWAS) and whole genome sequencing (WGS) approaches were used to identify genetic variants that modify the blood metabolome to identify signatures of human disease.

Authors: Gregory A. Michelotti, Silvia Grant, Patricia Sheridan


Offered Free by: Metabolon
See All Resources from: Metabolon

VIEW NOW

Recommended for Professionals Like You: